Back

Management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes

28 August 2022 (13:15 - 13:55)
Organised by:
Congress Presentation Part of: Chronic heart failure - Epidemiology, prognosis, outcome 1 Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Santiago Jimenez-Marrero

University Hospital of Bellvitge, Barcelona (Spain)

5 More presentations in this session

Presentation thumbnail
Disease progression of heart failure in type 2 diabetes patients in Germany; a real world data analysis using health insurance claims data
Professor F. Koehler (Berlin, DE)
Abstract Slides
Presentation thumbnail
Can left ventricle mass index predict pacemaker-induced cardiomyopathy in patients with dual chamber permanent pacemakers implanted due to complete atrioventricular block?
Associate Professor T. Cinar (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Verification of the impact of changes in nutritional status after discharge of heart failure on cardiorenal anemia and the prognosis of HFpEF from the PURSUIT-HFpEF registry
Doctor T. KITAO (Osaka, JP)
Abstract Slides
Presentation thumbnail
Prognoses of 'high-profile' diseases: five-year survival following hospitalization with previous cancer compared to previous heart failure.
Professor L. Fauchier (Tours, FR)
Abstract Slides
Presentation thumbnail
Differences in chronic heart failure treatment between patients with and without obesity in a large real-world heart failure population
Ms Y. Aga (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - Epidemiology, prognosis, outcome 1

The Event

Event poster

ESC Congress 2022

28 August 2022 13:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources